SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-22-005956
Filing Date
2022-02-08
Accepted
2022-02-08 17:11:03
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea154944-f1_altamiratherap.htm F-1 305464
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, SPECIAL BERMUDA COUNSEL TO THE COMPAN ea154944ex5-1_altamirathe.htm EX-5.1 21987
3 CONSENT OF DELOITTE AG ea154944ex23-1_altamirathe.htm EX-23.1 2768
4 FILING FEE TABLE ea154944ex-fee_altamirathe.htm EX-FILING FEES 25603
5 GRAPHIC img_001.jpg GRAPHIC 14588
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4298
  Complete submission text file 0001213900-22-005956.txt   383426
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-262592 | Film No.: 22602649
SIC: 2834 Pharmaceutical Preparations